Trial Search

Current Search Criteria:

Intervention: BYETTA treatment
Found 225 matching trials

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

NA

This is a retrospective cohort study of patients with T2DM who were treated...

Status

Recruiting

Location

China, Jiangsu, Department of Endocrinology

Start Date

2024-01-01

Trial ID

NCT06256419

A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes

PHASE3

Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...

Status

Withdrawn

Location

Intarcia Therapeutics, Inc

Start Date

2013-02

Trial ID

NCT01455883

Treatments Being Tested

The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

PHASE4

Polycystic ovary syndrome (PCOS) is a health problem that affects one in 10...

Status

Completed

Location

The Second Affiliated Hospital, Third Military Medical University

Start Date

2017-07-01

Trial ID

NCT03151005

A Study to Evaluate ITCA 650 Compared to Glimepiride as Add on Therapy for the Treatment of Type 2 Diabetes

PHASE3

Phase 3 study to examine treatment with ITCA 650 compared to glimepiride wh...

Status

Withdrawn

Location

Intarcia Therapeutics, Inc

Start Date

2013-02

Trial ID

NCT01455922

Treatments Being Tested

Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

PHASE4

People with type 2 diabetes experience heart failure more often than do peo...

Status

Terminated

Location

Baylor College of Medicine

Start Date

2009-07

Trial ID

NCT00799435

Treatments Being Tested

Effect on Beta Cell Function and Glycaemic Control After Insulin and Exenatide Sequential Therapy

PHASE4

Whether GLP-1 receptor agonists sequential therapy in newly diagnosed type ...

Status

Unknown

Location

Xiaolong Zhao

Start Date

2014-02

Trial ID

NCT02129985

Treatments Being Tested

An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

PHASE3

The primary purpose of this study is to assess the anti-exenatide-antibody ...

Status

Completed

Location

Research Site

Start Date

2007-08

Trial ID

NCT00516048

Treatments Being Tested

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

PHASE3

The objectives of this clinical trial are to compare the effects of exenati...

Status

Completed

Location

Research Site

Start Date

2009-07

Trial ID

NCT00935532

The Effects of Exenatide on Oral Contraceptive Pharmacokinetics in Healthy Females

PHASE1

The purpose of this study is the examine the effect of taking exenatide on ...

Status

Completed

Location

Research Site

Start Date

2005-11

Trial ID

NCT00254800

Changes in Bone Turnover With Exposure to a GLP-1 Receptor Agonist

PHASE4

The purpose of this study is to determine changes in bone turnover markers ...

Status

Terminated

Location

University of Alabama at Birmingham

Start Date

2011-02

Trial ID

NCT01381926

Treatments Being Tested